| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,605 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$2,961,135 |
|
|
|
Indirect Value
|
$4,293,476 |
|
|
| Total
Shares |
351,824 |
|
|
| Total
Value |
$7,254,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 30.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-02-05 |
4 |
OE |
$5.28 |
$41,480 |
D/D |
7,856 |
7,856 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-01 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
5,775 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-04 |
4 |
OE |
$5.28 |
$30,957 |
D/D |
5,863 |
5,863 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-05 |
4 |
OE |
$5.28 |
$30,951 |
D/D |
5,862 |
5,862 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-14 |
4 |
OE |
$5.28 |
$2,640 |
D/D |
500 |
500 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-01 |
4 |
OE |
$5.28 |
$30,492 |
D/D |
5,775 |
5,775 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-02 |
4 |
OE |
$5.28 |
$32,393 |
D/D |
6,135 |
6,135 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-02 |
4/A |
OE |
$5.28 |
$32,958 |
D/D |
6,242 |
6,242 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-03 |
4 |
OE |
$5.28 |
$30,951 |
D/D |
5,862 |
5,862 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
OE |
$5.28 |
$13,797 |
D/D |
2,613 |
2,613 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
OE |
$5.28 |
$14,008 |
D/D |
2,653 |
2,653 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
OE |
$5.28 |
$13,443 |
D/D |
2,546 |
2,546 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-06-10 |
4 |
OE |
$5.28 |
$24,378 |
D/D |
4,617 |
3,906 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
OE |
$5.28 |
$34,378 |
D/D |
6,511 |
7,988 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
52,518 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-02-07 |
4/A |
OE |
$0.00 |
$0 |
D/D |
4,250 |
4,250 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-08-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,643 |
8,465 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-10-08 |
4 |
OE |
$5.28 |
$120,944 |
I/I |
22,906 |
189,523 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-10-09 |
4 |
OE |
$5.28 |
$158,400 |
I/I |
30,000 |
196,617 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-02-07 |
4 |
OE |
$0.00 |
$0 |
I/I |
4,250 |
169,391 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-03-30 |
4 |
S |
$19.48 |
$27,817 |
D/D |
(1,428) |
2,822 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-02-09 |
4 |
S |
$74.40 |
$109,785 |
I/I |
(1,470) |
167,921 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-02-11 |
4 |
S |
$70.17 |
$221,972 |
I/I |
(3,156) |
172,233 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2021-08-19 |
4 |
S |
$49.31 |
$126,230 |
I/I |
(2,546) |
164,773 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2022-01-05 |
4 |
S |
$44.78 |
$127,399 |
I/I |
(2,845) |
163,285 |
0 |
% |
|
108 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
